Offerings // Greenwich LifeSciences, Inc.

GLSI offering history

Every offering-related filing in Greenwich LifeSciences, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 279 filings back to Jan 27, 2020.

Last executed offering

Jun 17, 2024

8-K — priced deal (shares or notes)

Last registration (announced)

Oct 7, 2024

S-3 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Oct 17, 2024	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Oct 7, 2024	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jun 17, 2024	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jul 12, 2022	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 6, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Apr 1, 2022	S-3/A →	REGISTERED	S-3/A registration — capacity to sell shares, not a sale yet
Mar 25, 2022	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Mar 8, 2021	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Dec 18, 2020	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)
Dec 17, 2020	S-1MEF →	REGISTERED	S-1MEF registration — capacity to sell shares, not a sale yet
Dec 17, 2020	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 16, 2020	FWP →	MARKETING	Free-writing prospectus — offering being marketed
Dec 15, 2020	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Nov 10, 2020	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Sep 28, 2020	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)
Sep 28, 2020	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)
Sep 24, 2020	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Sep 22, 2020	FWP →	MARKETING	Free-writing prospectus — offering being marketed
Sep 10, 2020	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Sep 9, 2020	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Jun 26, 2020	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Jun 23, 2020	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Jun 23, 2020	FWP →	MARKETING	Free-writing prospectus — offering being marketed
May 29, 2020	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet

GLSI offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full GLSI workspace →

GLSI offering FAQ

When did GLSI last execute an offering?

Per SEC filings, Greenwich LifeSciences, Inc.'s most recent priced offering document is a 8-K filed 2024-06-17. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did GLSI last announce or register an offering?

The most recent registration is a S-3 filed 2024-10-07. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.